The spectrum of neuromyelitis optica

被引:1911
作者
Wingerchuk, Dean M.
Lennon, Vando A.
Lucchinetti, Claudia F.
Pittock, Seanj
Weinshenker, Brian G.
机构
[1] Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA
[2] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Scottsdale, AZ 85259 USA
[3] Mayo Clin, Coll Med, Dept Immunol, Scottsdale, AZ 85259 USA
关键词
D O I
10.1016/S1474-4422(07)70216-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord. Neuromyelitis optica has a worldwide distribution, poor prognosis, and has long been thought of as a variant of multiple sclerosis; however, clinical, laboratory, immunological, and pathological characteristics that distinguish it from multiple sclerosis are now recognised. The presence of a highly specific serum autoantibody marker (NMO-IgG) further differentiates neuromyelitis optica from multiple sclerosis and has helped to define a neuromyelitis optica spectrum of disorders. NMO-IgG reacts with the water channel aquaporin 4. Data suggest that autoantibodies to aquaporin 4 derived from peripheral B cells cause the activation of complement, inflammatory demyelination, and necrosis that is seen in neuromyelitis optica. The knowledge gained from further assessment of the exact role of NMO-IgG in the pathogenesis of neuromyelitis optica will provide a foundation for rational therapeutic trials for this rapidly disabling disease.
引用
收藏
页码:805 / 815
页数:11
相关论文
共 121 条
[1]   Aquaporin water channels: molecular mechanisms for human diseases [J].
Agre, P ;
Kozono, D .
FEBS LETTERS, 2003, 555 (01) :72-78
[2]  
AKMANDEMIR G, 2006, MULT SCLER, V12, pS157
[3]   The molecular basis of water transport in the brain [J].
Amiry-Moghaddam, M ;
Ottersen, OP .
NATURE REVIEWS NEUROSCIENCE, 2003, 4 (12) :991-1001
[4]   Devic's neuromyelitis Optica treated with intravenous gamma globulin (IVIG) [J].
Bakker, J ;
Metz, L .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (02) :265-267
[5]  
Barbieri F, 1989, Acta Neurol (Napoli), V11, P247
[6]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[7]   Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations [J].
Bergamaschi, R ;
Tonietti, S ;
Franciotta, D ;
Candeloro, E ;
Tavazzi, E ;
Piccolo, G ;
Romani, A .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (01) :2-4
[8]   Spinal cord abnormalities in recently diagnosed MS patients [J].
Bot, JCJ ;
Barkhof, F ;
Polman, CH ;
Nijeholt, GJLA ;
de Groot, V ;
Bergers, E ;
Ader, HJ ;
Castelijns, JA .
NEUROLOGY, 2004, 62 (02) :226-233
[9]   MS and neuromyelitis optics in Martinique (French West Indies) [J].
Cabre, P ;
Heinzlef, O ;
Merle, H ;
Buisson, GG ;
Bera, O ;
Bellance, R ;
Vernant, JC ;
Smadja, D .
NEUROLOGY, 2001, 56 (04) :507-514
[10]   Devic disease with brainstem lesions [J].
Chalumeau-Lemoine, L ;
Chretien, F ;
Si Larbi, AG ;
Brugieres, P ;
Gray, F ;
Brun-Buisson, C ;
Creange, A .
ARCHIVES OF NEUROLOGY, 2006, 63 (04) :591-593